Scarica l'app Stockscreener
1.41
2.08%
-0.03
Dopo l'orario di chiusura:
1.41
Precedente Chiudi:
$1.44
Aprire:
$1.44
Volume 24 ore:
285.87K
Relative Volume:
1.06
Capitalizzazione di mercato:
$73.25M
Reddito:
-
Utile/perdita netta:
$-51.47M
Rapporto P/E:
-1.41
EPS:
-1
Flusso di cassa netto:
$-47.50M
1 W Prestazione:
+6.02%
1M Prestazione:
+29.36%
6M Prestazione:
+2.92%
1 anno Prestazione:
-14.55%
Intervallo 1D:
$1.37
$1.4667
Intervallo di 1 settimana:
$1.27
$1.50
Portata 52W:
$0.81
$1.82
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Nome
Pmv Pharmaceuticals Inc
Settore
Industria
Telefono
(609) 642-6670
Indirizzo
400 ALEXANDER PARK DRIVE, PRINCETON
Confronta PMVP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.41 | 74.81M | 0 | -51.47M | -47.50M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-05-13 | Iniziato | Craig Hallum | Buy |
| 2024-04-12 | Iniziato | Jefferies | Buy |
| 2023-12-27 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-03-02 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-09-22 | Aggiornamento | Goldman | Neutral → Buy |
| 2021-08-19 | Iniziato | Oppenheimer | Perform |
| 2021-08-02 | Iniziato | Guggenheim | Buy |
| 2021-07-29 | Iniziato | H.C. Wainwright | Buy |
| 2020-10-20 | Iniziato | BofA Securities | Buy |
| 2020-10-20 | Iniziato | Cowen | Outperform |
| 2020-10-20 | Iniziato | Evercore ISI | Outperform |
| 2020-10-20 | Iniziato | Goldman | Neutral |
Mostra tutto
Pmv Pharmaceuticals Inc Borsa (PMVP) Ultime notizie
What analysts say about PMV Pharmaceuticals Inc. stockSkyrocketing returns - PrintWeekIndia
Best Electric Vehicle Stocks in India Premium Investment RecommendationsOutperformance with explosive growth - Autocar Professional
Is PMV Pharmaceuticals Inc. stock overhyped or has real potentialStrong return on assets - jammulinksnews.com
Why PMV Pharmaceuticals Inc. stock attracts strong analyst attentionFree Access to Community - Newser
What analysts say about PMV Pharmaceuticals Inc. stock outlookTrend Following Trades - Newser
What drives PMV Pharmaceuticals Inc. stock priceSuperior risk-adjusted returns - Autocar Professional
Is PMV Pharmaceuticals Inc. a good long term investmentOutstanding investment returns - Autocar Professional
What analysts say about IRIDEX Corporation stockFree Expert Stock Watchlist - Autocar Professional
PMV Pharmaceuticals Inc. Stock Analysis and ForecastExceptional market performance - Autocar Professional
What analysts say about SAGE stockRemarkably fast returns - Autocar Professional
NECB Stock Analysis and ForecastRobust investment performance - Autocar Professional
CHSN Stock Analysis and ForecastFree Trading Psychology Coaching - jammulinksnews.com
What drives TopBuild Corp. stock priceGame-changing capital returns - jammulinksnews.com
What analysts say about Advantage Solutions Inc. stockMassive wealth growth - jammulinksnews.com
How PMV Pharmaceuticals Inc. stock performs during market volatilityMassive Upside Selection - Newser
Exploring India’s Stock Market through ETFs and Mutual Funds Consistent Stock Market ReturnsUnmatched profit potential - PrintWeekIndia
What drives Assurant Inc. stock priceMarket-beating performance - PrintWeekIndia
Benares Hotels Limited (509438) to Launch New Product LineSuperior returns - jammulinksnews.com
Is Red River Bancshares Inc. a good long term investmentDynamic investment growth - jammulinksnews.com
Best Stocks for Long Term Capital Appreciation in India Expert Selected High Growth StocksFree Consultation - Autocar Professional
What drives ATLCP stock priceTremendous wealth creation - jammulinksnews.com
Top Green Stocks to Buy Expert Verified Trading AlertsAccelerated profit realization - jammulinksnews.com
P 500 Structured Alt Protection Etf February stock priceTriple-digit profit margins - jammulinksnews.com
What analysts say about Big 5 Sporting Goods Corporation stockFree Stock Market Trend Analysis - jammulinksnews.com
Is Lesaka Technologies Inc. a good long term investmentRapid portfolio appreciation - jammulinksnews.com
Is Zynex Inc. a good long term investmentExceptional stock performance - jammulinksnews.com
KILO(kiloex) Price TodayCapital Growth Picks - Newser
BLID(bolide) Project ReviewFree Stock Market Analysis Courses - Newser
How High Can MVX(metavault trade) GoFree Exclusive Stock Market Insights - Newser
Real time deep learning model training with quantum cloud solutionsReal Trader Insights - Newser
Is KCS(kcs) a Good InvestmentFree Access to Group - Newser
Pmv Pharmaceuticals Inc Azioni (PMVP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Pmv Pharmaceuticals Inc Azioni (PMVP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Jalota Deepika | Chief Development Officer |
Jul 01 '25 |
Sale |
1.06 |
33,065 |
35,198 |
89,959 |
| Carulli Michael | Chief Financial Officer |
Jul 01 '25 |
Sale |
1.06 |
28,249 |
30,077 |
60,146 |
| Mack David Henry | President and CEO |
Jul 01 '25 |
Sale |
1.06 |
58,411 |
62,179 |
536,133 |
| Mack David Henry | President and CEO |
Dec 03 '24 |
Option Exercise |
0.53 |
91,750 |
48,628 |
534,210 |
| Mack David Henry | President and CEO |
Jan 03 '25 |
Option Exercise |
0.53 |
17,709 |
9,386 |
551,919 |
| Jalota Deepika | Chief Development Officer |
Sep 11 '24 |
Sale |
1.50 |
7,218 |
10,853 |
118,283 |
| Carulli Michael | Chief Financial Officer |
Sep 11 '24 |
Sale |
1.50 |
2,891 |
4,347 |
88,395 |
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):